Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.

Nophar GeifmanRoberta Diaz BrintonRichard E KennedyLon S SchneiderAtul J Butte

Published in: Alzheimer's research & therapy (2017)

These results indicate that the use of statins may benefit all AD patients with potentially greater therapeutic efficacy in those homozygous for ApoE4.

Keyphrases

cognitive decline
mild cognitive impairment
cardiovascular disease
metabolic syndrome
adipose tissue
insulin resistance